Some people with IgA nephropathy take regular steroids, budesonide (Tarpeyo), or SGLT-2 inhibitors to lower the amount of protein in their urine. Swollen legs and feet. With kidney disease ...

As this scarring worsens, some people with IgA develop end-stage kidney disease (also known as end-stage renal disease, or ESRD) and need dialysis or a kidney transplant. Only about 200,000 people ...

Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...

Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of ...

IgA nephropathy is a chronic condition that ... limit kidney damage and delay kidney failure in people with chronic kidney disease. People with kidney failure often get dialysis while they ...

Novartis’ Vanrafia (atrasentan) has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat ...

Vanrafia (atrasentan) is the first drug in the selective endothelin A receptor antagonist (ERA) class to be cleared in the US ...

Adults recently diagnosed with immunoglobulin A nephropathy who were assigned sparsentan as first-line therapy experienced rapid and sustained reductions in proteinuria, according to ...

Immunoglobulin A nephropathy (also known as IgA nephropathy or Berger's disease) is a condition that causes IgA antibodies to accumulate in the kidneys—leading to damage that affects their blood ...

Immunoglobulin A nephropathy (known as IgA nephropathy or Berger's disease) is a rare kidney disease that occurs when the body's immune system response causes IgA antibodies to build up in the ...